Package 50228-338-31

{"route": ["ORAL"], "spl_id": "d9b7b0d0-71db-578b-e053-2a95a90a8514", "openfda": {"upc": ["0350228338110", "0350228338615", "0350228338318"], "unii": ["ZG7E5POY8O"], "rxcui": ["1801289"], "spl_set_id": ["2bb61b34-653a-43b4-9682-705d5b82d18e"], "manufacturer_name": ["ScieGen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-338-11)", "package_ndc": "50228-338-11", "marketing_start_date": "20190501"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-338-31)", "package_ndc": "50228-338-31", "marketing_start_date": "20190501"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-338-61)", "package_ndc": "50228-338-61", "marketing_start_date": "20190501"}], "brand_name": "Bupropion Hydrochloride (SR)", "product_id": "50228-338_d9b7b0d0-71db-578b-e053-2a95a90a8514", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50228-338", "generic_name": "bupropion hydrochloride", "labeler_name": "ScieGen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(SR)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206122", "marketing_category": "ANDA", "marketing_start_date": "20190501", "listing_expiration_date": "20261231"}